Alzheimer’s Disease (AD) is the world’s most common reason for progressive dementia, especially in elderly population. The worst thing about AD is the fact that the number of cases where it appears has been growing exponentially and there isn’t an effective treatment for it. The Alzheimer’s Association published a report where is showed that an estimated 5.4 million Americans of all ages are affected by AD. The report refers to 2016 and the number of affected people is significantly bigger now in 2018.
Alzheimer’s Disease in the Future
The report also estimated that the number of people over 65 years old who are affected by AD is going to triple by 2050. This means that there will be 16.2 million elderly Americans who will suffer from AD in the nearby future and there will not be any treatment that can cure or advert the disease.
High Mortality Rate
The mortality rate has been getting higher and higher. While deaths from heart disease, prostate cancer and strokes have decreased to 14%, 11% and 23%, the number of deaths from AD has increased to 71%. This study was conducted in the US, but there are 46.8 million affected by AD all around the world. These people are living with dementia and their state is getting worse by the day.
Despite their best efforts, drug manufacturers are not able to identify a treatment for AD. In addition, drug manufacturers are also restricted from validating significant clinical benefits of treatment for different new compounds because of strict regulations.
On the other hand, the market is collaborating with an already existing player such as diagnostic technology companies who are trying to introduce biomarker technologies which can support and improve the drug development process. Therefore, drug manufacturers might be able to produce new drug candidates which could provide a treatment for AD.
Brad is a former Senior Fellow at the Schuster Institute for Investigative Journalism at Brandeis University, is an award-winning travel, culture, and parenting writer. His writing has appeared in many of the Canada’s most respected and credible publications, including the Toronto Star, CBC News and on the cover of Smithsonian Magazine. A meticulous researcher who’s not afraid to be controversial, he is nationally known as a journalist who opens people’s eyes to the realities behind accepted practices in the care of children. Brad is a contributing journalist to Advocator.ca